fda compounding semaglutide crackdown september 2025 to Restrict Ingredients Used in Mass-Marketed Compounded GLP-1s, Crack Down on Misleading Ads FDA issued 25 warning letters

Funding Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature

Monitoring and safety Regular monitoring helps catch problems early regardless of product source

Glutathione clears all three GLP-1 safety screens glucose effects, GI burden, and CYP/absorption interference making it lower-risk than many supplements people commonly stack with weight-loss medications

Increases in the levels of intracellular aspartate via SLC1A3 contribute to nucleotide synthesis and maintain the electron transport chain and TCA cycle 114

Treatment duration is generally limited to 812 weeks before cycling off to evaluate response [9]

Implement Cycling